US Patent 7229640 Paroxetine controlled release compositions
Patent 7229640 was granted and assigned to Smithkline Beecham Limited on June, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
David Philip Elder0
Graham Stanley Leonard0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+142 characters)
Article
Patent abstract
A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07229640 Paroxetine controlled release compositions US Patent 7229640 Paroxetine controlled release compositions
Infobox
Patent Number
072296400
Patent Number
72296400
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072296400
Date of Patent
June 12, 2007
0Patent Application Number
100248580
Date Filed
December 18, 2001
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07229640 Paroxetine controlled release compositions
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07229640
Date of patent
June 12, 2007
Patent application number
10024858
Date Filed
December 18, 2001
Patent primary examiner
Find more entities like US Patent 7229640 Paroxetine controlled release compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
